IMMUNE MODULATION WITH TLR9 AGONISTS FOR CANCER TREATMENT

COMBINATION THERAPY INCLUDING SAPC-DOPS FOR THE TREATMENT OF PANCREATIC CANCER

Methods for treatment of diseases

ANTIDIABETIC MEDICATIONS

PAC-1 COMBINATION THERAPY

METHOD AGAINST CORONAVIRUS INFECTION WITH QUINOLINE COMPOUND

MODULATING PTPN2 TO INCREASE IMMUNE RESPONSES AND PERTURBING GENE EXPRESSION IN HEMATOPOIETIC STEM CELL LINEAGES

Compounds and Methods for Use in Dystrophin Transcript

USE OF MESENCHYMAL STEM CELLS IN THE TREATMENT OF VIRAL INFECTIONS AND/OR COMPLICATIONS CAUSED BY VIRAL INFECTIONS

Anti-TMPRSS2 antibodies and antigen-binding fragments

REGIMENS AND METHODS OF TREATING MULTIPLE SCLEROSIS USING OFATUMUMAB

BOTULINUM TOXIN PREFILLED PLASTIC SYRINGE

COMPOSITIONS AND METHODS FOR GENE EDITING FOR HEMOPHILIA A

Subcutaneous administration of ADAMTS13

COMPOSITION COMPRISING A COLLAGEN HYDROLYSATE AND A FUCOIDAN

Composition for ameliorating psoriasis symptoms containing extract of L

Composition for ameliorating psoriasis symptoms containing extract of

AGENT FOR PROMOTING EXPRESSION OF N-ACETYLGALACTOSAMINYLTRANSFERASE CONTAINING EXTRACT FROM INFLAMED TISSUES INOCULATED WITH VACCINIA VIRUS

METHOD FOR IMPROVING VISUAL ACUITY

Cultured thymus tissue transplantation promotes donor-specific tolerance to allogeneic solid organ transplants

METHOD OF TREATING OR AMELIORATING SKIN CONDITIONS WITH A MAGNETIC DIPOLE STABILIZED SOLUTION

METHOD FOR MITIGATION OF NON-ALCOHOLIC FATTY LIVER DISEASE BY USE OF A COMPOSITION COMPRISING SMALL-MOLECULE FUCOIDAN AND FUCOXANTHIN

RNAi agents for Hepatitis B virus infection

SERPINC1 iRNA Compositions and Methods of Use Thereof

Antisense oligonucleotides and uses thereof

CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS

Testosterone ester triglyceride formulations

ARIPIPRAZOLE PRODRUG COMPOSITION

Macrophages/microglia in neuro-inflammation associated with neurodegenerative diseases

Method of manufacturing stable emulsions and compositions containing the same

OCULAR IMPLANT CONTAINING A TYROSINE KINASE INHIBITOR

Injectable slurries and methods of manufacturing the same

COMPOUNDS AND METHODS FOR MODULATION OF SMN2

MIXTURES OF ANTIBODIES

Antibody that binds to VEGF-A and ANG2 and methods of use

Relaxin fusion polypeptides and uses thereof

VACCINES AGAINST HEPATITIS B VIRUS

Composition and methods for treatment of ornithine transcarbamylase deficiency

ASH1L degraders and methods of treatment therewith

Pharmaceutical compositions having improved storage stability

FULVESTRANT FORMULATIONS

Noble metal nanoparticles with radial pores

ULTRASOUND-INDUCED CONVECTION FOR DRUG DELIVERY AND TO DRIVE GLYMPHATIC OR LYMPHATIC FLOWS

Rapid-acting insulin compositions

BOLAAMPHIPHILIC COMPOUNDS, COMPOSITIONS AND USES THEREOF

Ready-To-Use Carfilzomib Compositions

TREATMENT OF DIABETIC PERIPHERAL NEUROPATHY USING PLACENTAL CELLS

CARDIOSPHERE-DERIVED CELLS AND EXOSOMES SECRETED BY SUCH CELLS IN THE TREATMENT OF MUSCULAR DYSTROPHY

Methods of inhibiting pathological angiogenesis

PREVENTION OF HIV-INFECTION

COMPOSITIONS AND METHODS FOR CANCER EXPRESSING PDE3A OR SLFN12

METHOD OF PROVIDING ARIPIPRAZOLE TO PATIENTS HAVING IMPAIRED CYP2D6 OR CYP3A4 ENZYME FUNCTION

SUSTAINED RELEASE BUPRENORPHINE MICROSPHERES (SRBM) AND METHODS OF USE THEREOF

PHARMACEUTICAL FORMULATIONS FOR SUSTAINED RELEASE OF SEBACOYL DINALBUPHINE ESTER

Ready-to-administer fentanyl formulations

METHODS OF ADMINISTERING IMMUNOSUPPRESSANTS HAVING A SPECIFIED PHARMACODYNAMIC EFFECTIVE LIFE AND THERAPEUTIC MACROMOLECULES FOR THE INDUCTION OF IMMUNE TOLERANCE

Ophthalmic pharmaceutical compositions and methods for treating ocular surface disease

Polynucleotides encoding Citrin for the treatment of Citrullinemia type 2

Polymer particles for neutrophil injury

Therapeutic constructs for co-delivery of mitotic kinase inhibitor and immune checkpoint inhibitor

SOLUTION AND METHOD FOR REDUCING THE VIRULENCE OF VIRUSES, BACTERIA, YEASTS, OR FUNGUS

SYSTEMS AND METHODS FOR PREPARING AND TRANSPORTING AN INJECTABLE SLURRY

DIPIVEFRIN ORALLY DISINTEGRATING TABLET FORMULATIONS

ENGINEERED ONCOLYTIC VIRUSES EXPRESSING PD-L1 INHIBITORS AND USES THEREOF

RNAi Agents And Compositions for Inhibiting Expression of Apolipoprotein C-III (APOC3)

Recombinant Glycoproteins and Uses Thereof

CELL MICROSHEET, SYRINGE CONTAINING THE CELL MICROSHEET, AND PRODUCTION AND USE OF THE CELL MICROSHEET

Cells engineered to express ultra-long acting insulin-Fc fusion proteins

T-CELL MODULATORY MULTIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF

D-amphetamine compounds, compositions, and processes for making and using the same

CRYSTALLINE EDG-2 RECEPTOR ANTAGONIST AND METHODS OF MAKING

Sodium thiosulfate-containing pharmaceutical compositions

Radiopharmaceutical and methods

Methods and agents to treat tumor cells and cancer

EXCIPIENT COMPOUNDS FOR PROTEIN FORMULATIONS

Methods of Treating Multiple Myeloma

TREATMENT OF ALZHEIMER'S DISEASE (AD) WITH AN ALUMINUM SALT

COLLECTING PHYSICAL THERAPY INFORMATION TO ENHANCE TREATMENT EFFICACY OF BOTULINUM TOXIN

METHODS OF DOWNREGULATING CCL20 GENES FOR TREATMENT OF TRAUMATIC BRAIN INJURIES

PHARMACEUTICAL COMPOSITION COMPRISING LACTOBACILLUS SAKEI WIKIM30 AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF CANCER

Enhancing AAV-mediated transduction of ocular tissues with hyaluronic acid

Biomaterials comprising hyaluronic acid binding peptides and extracellular matrix binding peptides for hyaluronic acid retention and tissue engineering applications

Injectable fosaprepitant composition

SYNERGIC PHARMACEUTICAL COMPOSITION OF ACECLOFENAC AND BETAMETHASONE FOR TREATING THE PAIN OF RHEUMATIC CONDITIONS OR POSTSURGICAL PAIN

PHARMACEUTICAL COMPOSITIONS OF VIBEGRON FOR REDUCING BODY FAT

Naltrexone injectable sustained release formulation

PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PARKINSON'S DISEASE

Stable nimodipine parenteral formulation

Powder injection of the donepezil semi palmoxiric acid salt, composition containing same and preparation method therefor

L-TRIIODOTHYRONINE (T3) FOR USE IN LIMITING MICROVASCULAR OBSTRUCTION

METHODS AND COMPOSITIONS OF SOLABEGRON FOR REDUCING BODY FAT

Compositions and methods for treating patients suffering from glioma or leukemia

DEXTROAMPHETAMINE AND LISDEXAMFETAMINE TO REVERSE DEXMEDETOMIDINE SEDATION

7-OH-cannabidiol (7-OH-CBD) and/or 7-OH-cannabidivarin (7-OH-CBDV) for use in the treatment of epilepsy

Self-Gelling Solutions for Administration of Therapeutics to the Inner Ear

Recombinant poxviruses for cancer immunotherapy

Crosslinking agent, preparation process and uses thereof, hydrogel and biodegradable cryogel comprising crosslinking agent

Anti-LAG-3 antibodies and compositions

AAV-EPO FOR TREATING COMPANION ANIMALS

Gene therapy for retinitis pigmentosa

In-situ stable injectable collagen-based hydrogels for cell and growth factor delivery

Stabilised Compositions of Factor VII Polypeptides

Methods for treatment of COVID-19 syndrome

LIQUID COMPOSITION COMPRISING PROTEIN

ANTIMICROBIAL FUSION PEPTIDES

DOSING REGIME AND FORMULATIONS FOR TYPE B ADENOVIRUSES

Scalable Production of Standardized Extracellular Vesicles, Extracellular Vesicle Preparations and Uses Thereof

Ferric Carboxymaltose In The Treatment Of Heart Failure And In The Treatment Of Congestion In Heart Failure

TREATMENT OF ACUTE MYELOID LEUKEMIA WITH HYPOMETHYLATING AGENTS AND 2-O, 3-O DESULFATED HEPARINOIDS

Compounds,compositions, and methods for the treatment of disease

METHODS OF TREATING RIGHT VENTRICULAR FUNCTION IN PULMONARY HYPERTENSION

Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 enzyme function

Treatment of gliomas using organonitro compound combination therapy

SUSTAINED LOCAL DRUG LEVELS FOR INNATE IMMUNE AGONISTS

Methods of treating myeloproliferative neoplasms

Salivary gland regeneration

TREATING INFECTIONS WITH CEFTOLOZANE/TAZOBACTAM IN SUBJECTS HAVING IMPAIRED RENAL FUNCTION

COMPOSITIONS FOR THE TREATMENT OF AUTODIGESTION

Infusion dosage form of norepinephrine

SUBCUTANEOUS ADMINISTRATION OF NANOPARTICLES COMPRISING AN MTOR INHIBITOR AND ALBUMIN FOR TREATMENT OF DISEASES

Relaxin immunoglobulin fusion proteins and methods of use

GIP/GLP1 co-agonist compounds

Compositions and methods for modulating inflammatory and degenerative disorder

AAV-IDUA vector for treatment of MPS I-associated blindness

Nanoparticle-Based Therapy of Inflammatory Disorders

Collagenase for treatment of bladder dysfunction

Combination Therapy for Treatment of Liver Disease

Angiotensin II alone or in combination for the treatment of hypotension

AAV-mediated BMI1 gene transfer for treating macular degeneration

Activated stem cells and systemic treatment methods for infected wounds

BETA-GLUCAN IN COMBINATION WITH ANTI-CANCER AGENTS AFFECTING THE TUMOR MICROENVIRONMENT

COMPOSITIONS AND METHODS FOR PROTECTING AGAINST AIRBORNE PATHOGENS AND IRRITANTS

TREATMENT METHOD WITH IAP INHIBITOR

Composition and methods for preventing or reducing the incidence of transient ischemic attacks

INJECTABLE SUSTAINED RELEASE BUPRENORPHINE FORMULATION

LONG ACTING IN-SITU FORMING/GELLING COMPOSITIONS

METHODS OF INHIBITION

Long-acting formulations

Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer

STABILIZED LIQUID FORMULATION OF LEVOTHYROXINE

MELFLUFEN DOSAGE REGIMENS FOR CANCER

Method of treating osteoarthritis

Medroxyprogesterone acetate injectable compositions and methods of use

Stable liquid formulation of AMG 416 (etelcalcetide)

Anti-FGFR2 antibodies in combination with chemotherapy agents in gastric cancer

HUMAN ANTI-IL-33 MONOCLONAL ANTIBODY-CONTAINING PHARMACEUTICAL COMPOSITION

SARS-COV-2 ANTIBODIES FOR TREATMENT AND PREVENTION OF COVID-19

GLUCAGON AND GLP-1 CO-AGONISTS FOR THE TREATMENT OF OBESITY

Radiopharmaceuticals, radioimaging agents, and uses thereof

Condensed-cyclic compound

Reagents and methods for cancer treatment using Magnetic particle

Lipid nanoparticle compositions and methods for mRNA delivery

FORMULATIONS WITH REDUCED DEGRADATION OF POLYSORBATE

Methods, agents and compositions as in situ vaccine for cancer cell and tumor treatment

Anti-IL-6 Antibody Formulation

Method of filling a container with no headspace

Composition and method of mRNA vaccines against novel coronavirus infection

Nucleoside-Modified RNA For Inducing an Adaptive Immune Response

METHOD OF TREATING A MAMMAL, INCLUDING HUMAN, AGAINST CANCER USING METHIONINE AND ASPARAGINE DEPLETION

STABILIZED PHARMACEUTICAL FORMULATIONS OF INSULIN ANALOGUES AND/OR INSULIN DERIVATIVES

Therapeutic RNA for Advanced Stage Solid Tumor Cancers

LIQUID POLYMER DELIVERY SYSTEM FOR EXTENDED ADMINISTRATION OF DRUGS

Methods and Compositions for Inhibition of Polymerase

INTRAVENOUS DMT ADMINISTRATION METHOD FOR DMT-ASSISTED PSYCHOTHERAPY

Antiviral treatments

Stable Acyclovir Sodium Parenteral Formulation

COMPOSITION FOR USE IN THE TREATMENT OF LESIONS IN THE MUCOSA BY MEANS OF ENDOSCOPIC RESECTION

Ready to use injectable formulations of Micafungin Sodium

Composition for submucosal injection and preparation method thereof

POLYNUCLEOTIDE AGENTS TARGETING PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) AND METHODS OF USE THEREOF

T-cell modulatory multimeric polypeptides and methods of use thereof

Medication infusion components and systems

Lyophilized Compositions Comprising Rhannexin V-128, Process for Their Preparation and Their Use for Preparing Formulations Containing 99MTc-Rhannexin V-128

ANIMAL PROTEIN-FREE PHARMACEUTICAL COMPOSITIONS

INHIBITOR OF EXTRACELLULAR TRAP FORMATION IN LEUKOCYTES

Therapeutic agent of uremia containing alarin as the main ingredient

METHODS OF TREATING PROSTATE CANCER WITH GnRH ANTAGONIST

Bioactive renal cells for the treatment of chronic kidney disease

Formulations of phosphoramidate derivatives of nucleoside drugs

Formulation comprising a gemcitabine-prodrug

NOVEL COMBINATION TREATMENT FOR ACUTE MYELOID LEUKEMIA (AML)

Injectable antibiotic formulations and use thereof

Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions

Buprenorphine dosing regimens

SYNERGIC PHARMACEUTICAL COMBINATION OF A LEUKOTRIENE-RECEPTOR ANTAGONIST AND AN INVERSE AGONIST OF HISTAMINE HI

Aqueous formulation comprising paracetamol and ibuprofen

Nanolipogel vehicles for controlled delivery of different pharmaceutical agents

INJECTION COMPOSITION CONTAINING FAB I INHIBITOR, AND PREPARATION METHOD THEREFOR

System and method for prostate treatment

Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor

MUSCULAR DYSTROPHY CHIMERIC CELLS AND METHOD FOR TREATING MUSCULAR DYSTROPHIES

Methods for reprograming non-pluripotent cells into pluripotent stem cells

Nucleic acid molecules encoding binding proteins for gastric inhibitory peptide receptor (GIPR)

COMPOSITIONS COMPRISING A P75 TUMOR NECROSIS FACTOR RECEPTOR/IG FUSION PROTEIN

Inhibitors of menin-mll interaction

Compounds and Their Use for Reducing Uric Acid Levels

Crystalline PPAR-delta agonist

Small molecule prolactin receptor inhibitors, pharmaceutical compositions and treatment methods using such inhibitors

Salts formed by 2-(1-acyloxy-n-pentyl) benzoic acid and basic amino acid or aminoguanidine, and preparation method and application thereof

Compounds and methods for delivery of prostacyclin analogs

PHARMACEUTICAL PREPARATION

Gene editing-based method of attenuating the beta-amyloid pathway

CONJUGATED ANTISENSE COMPOUNDS AND THEIR USE

Chimeric small molecules for the recruitment of antibodies to cancer cells

Pharmaceutical composition comprising anti-human TSLP receptor antibody

COMBINATION PRODUCT FOR USE IN TUMOR VACCINATION

Use of prourokinase and its variants against coagulopathy caused by viruses

METHODS FOR DESENSITIZATION OF URICASE

Compositions and methods for inhibiting intercellular interactions

Compositions Comprising CD34+ Cells and Methods for Repairing a Lung Injury After Severe Virus Infection

ALLOGENEIC CELL THERAPY OF ACUTE LYMPHOBLASTIC LEUKEMIA USING GENETICALLY ENGINEERED T CELLS TARGETING CD19

Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection

Use of dantrolene and dantrolene prodrugs to treat radiation exposure

System and method for treatment of bone

Neuroactive steroids, compositions, and uses thereof

Pharmaceutical combinations for the treatment of cancer

Ready to Use Ketorolac Formulations

Process of Manufacturing a Stable, Ready to Use Infusion Bag for an Oxidation Sensitive Formulation

Lyophilized preparation of prostaglandin E1 methyl ester for injection and production and use thereof

Stable formulations of lipids and liposomes

Phenylephrine hydrochloride ready-to-use solution

FORMULATIONS FOR PARENTERAL DELIVERY OF COMPOUNDS AND USES THEREOF

Humanized BCMA antibody and BCMA-CAR-T cells

Methods of Treating Inflammatory Pain

Ultra-long acting insulin-Fc fusion proteins and methods of use

COMPOSITION COMPRISING CATALASE, PREPARATION METHOD AND USE THEREOF AND METHOD FOR KILLING TUMOR CELLS

Radiopaque monomers, polymers, microspheres, and methods related thereto

Materials and methods for delivering nucleic acids to cochlear and vestibular cells

Pharmaceutical composition containing a hyaluronic acid derivative

Branched amino acid surfactants for use in healthcare products

PHARMACEUTICAL ANTI-TNF-ALPHA ANTIBODY FORMULATION

Method of producing pharmaceutical compositions comprising immunogenic chikungunya virus CHIKV-Delta5NP3

Aflibercept formulations and uses thereof

Daptomycin formulations containing a combination of sorbitol and mannitol

PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CYSTIC FIBROSIS

METHODS OF INCREASING TONIC INHIBITION AND TREATING SECONDARY INSOMNIA

COMPOUNDS FOR TREATING LYMPHOMA OR A T-CELL MALIGNANT DISEASE

Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof

PREMIXED, READY TO USE PHARMACEUTICAL COMPOSITIONS OF AMIODARONE

EPINEPHRINE PARENTERAL FORMULATIONS

Alcohol-based compositions and uses thereof

METHOD FOR TREATING MYOPIA AND APPLICATION IN PREPARATION OF MEDICAMENT

HIGH CONCENTRATION ANTI-TNFalpha ANTIBODY LIQUID FORMULATIONS

Ultra-long acting insulin-Fc fusion proteins and methods of use

Immunogenic composition against avian influenza virus H5 subtype

Compositions and Structures for Regenerating Defective or Absent Myocardium

Methods for Regenerating Defective or Absent Myocardium

Radiopharmaceutical and methods

Materials and methods for treatment of hereditary haemochromatosis

NOVEL NANOPARTICLES OF ANTIRETROVIRAL DRUGS, THEIR PREPARATION AND THEIR USE FOR THE TREATMENT OF VIRAL INFECTIONS

METHODS OF TREATING OR PREVENTING STENT THROMBOSIS

TREATMENT OF SEVERE ACUTE RESPIRATORY SYNDROME-RELATED CORONAVIRUS INFECTION WITH KLOTHO

PTH Prodrugs

METHOD OF TREATING A TUMOR WITH A COMBINATION OF IL-7 PROTEIN AND AN IMMUNE CHECKPOINT INHIBITOR

ANTI-CANCER MONOTHERAPY USING SA-4-1BBL

TUMOR TREATMENT USING CYTOKINES AND CANCER DRUGS

COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING SEPSIS

APPLICATION OF PHLEGMYHEATCLEAR IN PREPARATION OF DRUG FOR TREATMENT OF ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Preparation and application of grain worm for treating diabetes

Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

METHODS, COMPOSITIONS, AND KITS FOR TREATING OCULAR DISEASES

Therapeutic, preventive, or improvement agent for inflammatory disease and allergic disease

FUSED IMIDAZO-PIPERIDINE JAK INHIBITOR COMPOUND

Methods of treatment using a JAK inhibitor compound

Compounds for controlling arthropods

Methods for improved endovascular thrombectomy using 3,3′-diindolylmethane

COMPOSITION COMPRISING CAPSAICIN OR A CAPSACINOID FOR POSTOPERATIVE PAIN CONTROL

PHARMACEUTICAL LIQUID COMPOSITIONS OF MELOXICAM

PHARMACEUTICAL BIODISSOLVABLE GELS FOR DRUG DELIVERY

Facile assembly of soft nanoarchitectures and co-loading of hydrophilic and hydrophobic molecules via flash nanoprecipitation

METHODS OF TREATING GRAVES' OPHTHALMOPATHY USING ANTI-FCRN ANTIBODIES

Solid forms and combination compositions comprising a beta-lactamase inhibitor and uses thereof

Compounds as neurokinin-1 receptor antagonists and uses thereof

CATIONIC LIPID COMPOSITIONS FOR TISSUE-SPECIFIC DELIVERY

RANDOM CONJUGATE MOLECULE AND METHODS OF MAKING AND USING THE SAME

Therapy for Treating Cancer with an Intratumoral or Intravenous Administration of a Recombinant MVA Encoding 4-1BBL (CD137L) and/or CD40L

NOVEL COMBINATIONS FOR ANTIGEN BASED THERAPY

LONG-ACTING COAGULATION FACTORS AND METHODS OF PRODUCING SAME

Modified therapeutic agents, stapled peptide lipid conjugates, and compositions thereof

COMBINATIONS OF LYSOBACTIN AND AMINOGLYCOSIDES AGAINST DISEASES CAUSED BY GRAM-POSITIVE AND GRAM-NEGATIVE BACTERIA IN NON-HUMAN ANIMALS

HUMAN PLATELET LYSATE DERIVED EXTRACELLULAR VESICLES FOR USE IN MEDICINE

Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

Enteric Use of Potassium Permanganate in Humans and Animals

Sulfated glycosaminoglycan biomaterials as proteoglycan mimics

Oligonucleotide Analogues Incorporating 5-Aza-Cytosine Therein

THERAPEUTIC AGENT COMPOSITION AND METHOD OF USE, FOR TREATMENT OF MILD CONGNITIVE IMPAIRMENT, DEPRESSION, AND PSYCHOLOGICAL DISORDERS

1',3'-Disubstituted-4-Phenyl-3,4,5,6-Tetrahydro-2H,1'H-[1,4']Bipyridinyl-2'-Ones

Use of bulleyaconitine A

Long-acting injection dosage form of beta 3 adrenoreceptor agonists

COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY NEUROLOGICAL DISORDERS

PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD THEREFOR

Methods for Administration and Methods for Treating Cardiovascular Diseases with Resiniferatoxin

Therapeutic agent for phosphodiesterase inhibition and its related disorders

AQUEOUS PAEDIATRIC RETINOL FORMULATIONS

CLEAR PROPOFOL INJECTION AND PREPARATION METHOD THEREFOR

PARENTERAL DOSAGE FORM OF AMIODARONE

HYALURONIC ACID COMPOSITION

Specific siRNA molecules, composition and use thereof for the treatment of triple negative breast cancer